This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1987:32:379-405.

Drug metabolism in patients with liver disease

J W Secor, S Schenker

PMID: 3548257

Review

Drug metabolism in patients with liver disease

J W Secor et al. Adv Intern Med. 1987.

. 1987:32:379-405.

Authors

J W Secor, S Schenker

PMID: 3548257

No abstract available

PubMed Disclaimer

Similar articles

[Pharmacokinetic mechanisms of drug interactions. 3: Interaction mechanisms during distribution].
Box A, Heydel E, Fürtig W. Box A, et al. Pharmazie. 1984 Mar;39(3):195-202. Pharmazie. 1984. PMID: 6728895 German. No abstract available.
[Drug therapy in liver diseases: problems in intensive care].
Follath F. Follath F. Schweiz Med Wochenschr. 1986 Apr 26;116(17):549-52. Schweiz Med Wochenschr. 1986. PMID: 3715434 German.
[Drug metabolism: chronic alcoholism and cirrhosis].
Martin P, Childs M. Martin P, et al. Sem Hop. 1983 Mar 3;59(9):632-9. Sem Hop. 1983. PMID: 6304914 Review. French.
The influence of liver diseases on drug disposition.
Roberts RK, Branch RA, Desmond PV, Schenker S. Roberts RK, et al. Clin Gastroenterol. 1979 Jan;8(1):105-21. Clin Gastroenterol. 1979. PMID: 369741 Review. No abstract available.
[Influence of disease on the metabolism and effects of drugs in man].
Lavigne JG. Lavigne JG. Union Med Can. 1980 Dec;109(12):1718-22. Union Med Can. 1980. PMID: 7210314 French. No abstract available.

See all similar articles

Cited by

Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
Silvain C, Bouquet S, Breux JP, Becq-Giraudon B, Beauchant M. Silvain C, et al. Eur J Clin Pharmacol. 1989;37(3):261-5. doi: 10.1007/BF00679781. Eur J Clin Pharmacol. 1989. PMID: 2612541
Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.
Crone CC, Gabriel GM. Crone CC, et al. Clin Pharmacokinet. 2004;43(6):361-94. doi: 10.2165/00003088-200443060-00002. Clin Pharmacokinet. 2004. PMID: 15086275 Review.
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.
Bodenham A, Shelly MP, Park GR. Bodenham A, et al. Clin Pharmacokinet. 1988 Jun;14(6):347-73. doi: 10.2165/00003088-198814060-00003. Clin Pharmacokinet. 1988. PMID: 3293870 Review.
Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.
Gubbins PO, Bertch KE. Gubbins PO, et al. Clin Pharmacokinet. 1991 Dec;21(6):431-47. doi: 10.2165/00003088-199121060-00004. Clin Pharmacokinet. 1991. PMID: 1782738 Review.
Guide to drug dosage in hepatic disease.
Bass NM, Williams RL. Bass NM, et al. Clin Pharmacokinet. 1988 Dec;15(6):396-420. doi: 10.2165/00003088-198815060-00004. Clin Pharmacokinet. 1988. PMID: 3072141 Review. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information